Jennifer E. Cook, Director at BridgeBio Pharma, Inc. (BBIO), sold 90,240 shares at $66.62 ($6.0M) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($6.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.62 | 88,737 | $5.9M | 98.3% |
| 2 | $67.14 | 1,503 | $101K | 1.7% |
| Total | $66.62 avg | 90,240 | $6.0M | 100% |
| Filing → |
| DNLI | SELL | 2024-06-10 | $32K | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |